Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Published Date: 18 Oct 2024

Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

2.

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

3.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Firefighters who eat better can combat cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot